Abstract:Background and purpose: The multidrug resistance of epilepsy may result from the overexpression of P-glycoprotein, but the mechanisms are unclear. We investigated whether the overexpression of P-glycoprotein in the brains of subjects with pharmacoresistant epilepsy resulted from both drug effects and seizure activity. Experimental approach: Kindled rats were developed by injecting a subconvulsive dose of pentylenetetrazole (33 mg center dot kg-1 center dot day-1, i.p.) for 28 days. Groups were then treated with an oral dose of phenobarbital (45 mg center dot kg-1 center dot day-1) for 40 days. In accord with behavioural observations, P-glycoprotein activity in brain was assessed using brain-to-plasma concentration ratios of rhodamine 123. P-glycoprotein levels in the brain regions were further evaluated using RT-PCR and Western blot analysis. The distribution of phenobarbital in the brain was assessed by measuring phenobarbital concentrations 1 h following its oral administration. Key results: The kindling significantly increased P-glycoprotein activity and expression. Good associations were found among P-glycoprotein activity, expression and phenobarbital concentration in the hippocampus. Short-term treatment with phenobarbital showed good anti-epileptic effect; the maximum effect occurred on day 14 when overexpression of P-glycoprotein was reversed. Continuous treatment with phenobarbital had a gradually reduced anti-epileptic effect and on day 40, phenobarbital exhibited no anti-epileptic effect; this was accompanied by both a re-enhancement of P-glycoprotein expression and decreased phenobarbital concentration in the hippocampus. P-glycoprotein function and expression were also increased in age-matched normal rats treated with phenobarbital. Conclusions and implications: The overexpression of P-glycoprotein in the brain of subjects with pharmacoresistant epilepsy is due to a combination of drug effects and epileptic seizures.

Effect of 21-Day Exposure of Phenobarbital, Carbamazepine and Phenytoin on P-glycoprotein Expression and Activity in the Rat Brain

Antiepileptic Drugs Up-Regulated Activity and Expression of P-glycoprotein in Blood-Brain Barrier of Rats

Increased P-glycoprotein Function and Level after Long-Term Exposure of Four Antiepileptic Drugs to Rat Brain Microvascular Endothelial Cells in Vitro

Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats.

Effect of diazoxide on regulation of vesicular and plasma membrane GABA transporter genes and proteins in hippocampus of rats subjected to picrotoxin-induced kindling.

P-glycoprotein Alters Blood–brain Barrier Penetration of Antiepileptic Drugs in Rats with Medically Intractable Epilepsy

In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein

Increased P-glycoprotein Expression and Decreased Phenobarbital Distribution in the Brain of Pentylenetetrazole-Kindled Rats

The transport of antiepileptic drugs by P-glycoprotein.

Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy

In Vitro Transport Profile of Carbamazepine, Oxcarbazepine, Eslicarbazepine Acetate, and Their Active Metabolites by Human P-glycoprotein

MRP is Involved in the Regulation of Concentration of Carbamazepine and Phenytoin in the Extracellular Fluid of the Cerebral Cortex of Rat

P-glycoprotein-mediated Efflux of Phenobarbital at the Blood-Brain Barrier Evidence from Transport Experiments in Vitro

Study the Function of P-glycoprotein in Modulating the Extracellular Levels of Carbamazepine in Hippocampus of Chronic Epileptic Rats

Repetitive/temporal Hypoxia Increased P-glycoprotein Expression in Cultured Rat Brain Microvascular Endothelial Cells in Vitro

Seizure-Induced Up-Regulation of P-Glycoprotein at the Blood-Brain Barrier through Glutamate and Cyclooxygenase-2 Signaling

Attenuated Function and Expression of P-glycoprotein at Blood–brain Barrier and Increased Brain Distribution of Phenobarbital in Streptozotocin-Induced Diabetic Mice

Involvement of p38 MAPK in the Drug Resistance of Refractory Epilepsy Through the Regulation Multidrug Resistance-Associated Protein 1

Effect of verapamil on electrobiological activity and seizure behavior in phenytoin-carbamazepine resistant rats

Overexpression of multidrug resistance-associated protein 2 in the brain of pentylenetetrazole-kindled rats.

Study on the reversal of epileptic drug resistance by tetramethylpyrazine in combination with carbamazepine through modulation of P-Glycoprotein expression in rat brain microvessel endothelial cell